Unknown NA INTERVENTIONAL 1-arm NCT04193995

Intermittent Fasting as a Means to Lose Fluid Overload and Weight in Complicated Obesity

Intermittent Fasting as a Means to Lose Fluid Overload and Weight in Complicated Obesity: a Pilot Feasibility Study

Sponsor: Tel-Aviv Sourasky Medical Center

Conditions Comorbidities and Coexisting Conditions Fluid Retention Intermittent Fasting Obesity, Morbid Weight Loss

Updated 6 times since 2020 Last updated: May 30, 2020 Started: Apr 1, 2019 Primary completion: Dec 31, 2020 Completion: Apr 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Comorbidities and Coexisting Conditions and Fluid Retention, this trial is ongoing. The trial is conducted by Tel-Aviv Sourasky Medical Center and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting NA
Jul 2020 — Jan 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jan 2020 — Jul 2020 [monthly]

Recruiting NA

First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tel-Aviv Sourasky Medical Center

Data source: Tel-Aviv Sourasky Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tel Aviv, Israel